Infliximab in Crohn's disease
38 results
1 - 38
Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease- Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
- Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
- Natalizumab for induction of remission in Crohn's disease
- Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
- Methotrexate for maintenance of remission in Crohn's disease: Cochrane systematic review
- Tumor necrosis factor‐alpha antibody for induction of remission in Crohn's disease
- Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease
- Interventions for prevention of post‐operative recurrence of Crohn's disease
- Enteral nutrition for maintenance of remission in Crohn's disease
- Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis
- Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
- Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
- Interventions for growth failure in childhood Crohn's disease
- Adalimumab for maintenance of remission in Crohn's disease
- Helminth therapy (worms) for induction of remission in inflammatory bowel disease: Cochrane systematic review
- Antibiotics for induction and maintenance of remission in Crohn's disease